Orthostasis Risk with SGLT-2 Inhibitors
Med Ed 101
DECEMBER 26, 2018
Orthostasis risk with SGLT-2 Inhibitors is a potential minor concern, particularly in our geriatric population. While a drop in blood pressure can be a good thing for a significant chunk of diabetes patients, that potential modest drop can lead to an increased risk of adverse effects as well.
40 
Let's personalize your content